AGA (Atlantic Gastroenterology Associates) has been an integral part of community since 1978 and is the recognized leader in southern NJ for excellence in digestive health services.

AGA is a seven gastroenterologist/six nurse practitioner group practice. Mission is to provide state of the art digestive health services for our community.

Therapeutic areas: Inflammatory Bowel Disease, Irritable Bowel Syndrome, Acid-related disorders, Gastroesophageal Reflux Disease, Hepatitis C, Crohn's Disease, Ulcerative Colitis.

Sponsors, CROs: AKPHARMA, Solvay/Quintiles, Novartis, Salix, Abbott Laboratories/Kendle International, Yamanouchi, Schering, Roche, Astra Zeneca, Icon, Centocor/PRA International, Otsuka Maryland Research Institute, Intermune, GlaxoSmithKline, Genzyme, Pharmalink FHI.

AGA Clinical Research Associates has been operating in various capacities since 1987.

AGA owns and operates a surgicenter/endoscopy center, and two office sites, one of which is accessible to public transportation.

AGA is the only clinical practice in the tri-state area to use the M2A Diagnostic Imaging Capsule. In addition, AGA performs all gastroenterologic procedures and testings presently available for patients, including on-site Pytesting, Hydrogen Breath Testing, EGG (electrogastrograph) and BRAVO catheter-free Ph monitoring.

Seven physicians are involved as principle investigators in various studies, all physicians are board certified and are expert in the entire field of gastroenterology and hepatology. Below are the interest areas of each physician:

• Barry Kaufman: Inflammatory Bowel Disease
• John Santoro: Hepatitis C, Acid related disorders, Inflammatory Bowel disease
• Joseph Spaar: Acid related disorders and liver Diseases
• Gary Rosman: Acid related disorders
• Howard Garson: Inflammatory Bowel Disease
• Nik Mehta
• John Chiesa

In addition, there includes six board certified nurse practitioners. Theresa Stevens, APN-C, CCRP is manager of clinical research. She has had experience in hematology-oncology trials in the past and has had extensive experience in the area of rheumatologic disorders.

The patient population of our practice has the typical demographics of the Northeast US population.

AGA draws from 55,000 active patients that reside primarily in Atlantic, Ocean, Camden and Cape May Counties, but also serves the tri-state area of NJ, Pennsylvania and Delaware.

AGA uses a central IRB

Additional contact persons:

Cindy Crush
General Office Manager
Phone: (609) 407-1220 ext 1146

Theresa Stevens RN, MSN, APN-C, CCRP
Research Director
Phone: (609) 407-1220 ext 1108
E-mail: theresa@atlanticgastro.com

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
• A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
• Do you have Crohn's Disease?
• Do You Have Crohn's Disease? Have You Received Infliximab (Remicade) Therapy?
• Do you suffer from Crohn's disease and have been unable to find a successful treatment option?
• Hepatitis C
• How do UC Life?

For more information, please contact:

Dr. Barry P. Kaufman / Dr. John J. Santoro
Medical Directors
Atlantic Gastroenterology Associates
3205 Fire Road
Egg Harbor Township, NJ 08234 USA
Phone: 609-407-1220 Ext. 1108
Fax: 609-407-1340
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on March 5, 2008

PAC>